Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Medprin Regenerative Medical Technologies Co's
Operating Income
for the
three
months ended in Jun. 2026 was ¥40.4 Mil. Medprin Regenerative Medical Technologies Co's Interest Expense for the
three
months ended in Jun. 2026 was ¥0.0 Mil.
Medprin Regenerative Medical Technologies Co's interest coverage for the quarter that ended in Jun. 2026 was 492.04.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. Medprin Regenerative Medical Technologies Co Ltd has enough cash to cover all of its debt. Its financial situation is stable.
SZSE:301033'
s Interest Coverage Range Over the Past 10 Years
Min: 18.58 Med: 96.22 Max: 6346.8
Current: 113.29
SZSE:301033's Interest Coverage is ranked better than 76.84% of 462
companies
in the Medical Devices & Instruments industry
Industry Median: 16.755
vs SZSE:301033: 113.29
Medprin Regenerative Medical Technologies Co (SZSE:301033) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Medprin Regenerative Medical Technologies Co Interest Coverage Related Terms
Medprin Regenerative Medical Technologies Co Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Medprin Regenerative Medical Technologies Co Interest Coverage Chart
Medprin Regenerative Medical Technologies Co Annual Data
SZSE:301033 vs ABT, SYK, MDT: Interest Coverage Comparison
For the Medical Devices subindustry, Medprin Regenerative Medical Technologies Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medprin Regenerative Medical Technologies Co Interest Coverage vs Medical Devices & Instruments Industry
Medprin Regenerative Medical Technologies Co Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
Medprin Regenerative Medical Technologies Co had no debt (1).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medprin Regenerative Medical Technologies Co (SZSE:301033) has a Interest Coverage of 492.04 as of Jun. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Medprin Regenerative Medical Technologies Co and its competitors. This is 411% above median its historical median of 96.22. Over the past decade, Medprin Regenerative Medical Technologies Co's Interest Coverage has ranged from 18.58 to 6,346.80. According to the industry distribution chart, Medprin Regenerative Medical Technologies Co ranks #107 out of 462 companies in the Medical Devices & Instruments industry, placing it in the top 23.2%.
Is Medprin Regenerative Medical Technologies Co's Interest Coverage too high?
Medprin Regenerative Medical Technologies Co's current Interest Coverage of 492.04 is 411% above median its 10-year median of 96.22. Over the past 10 years, this metric has ranged from a low of 18.58 to a high of 6,346.80. The Medical Devices & Instruments industry median Interest Coverage is 16.76. Medprin Regenerative Medical Technologies Co's value of 492.04 is 2836.7% above this industry median. Based on the distribution chart, Medprin Regenerative Medical Technologies Co ranks #107 out of 462 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Medprin Regenerative Medical Technologies Co has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medprin Regenerative Medical Technologies Co's Interest Coverage compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medprin Regenerative Medical Technologies Co ranks #107 out of 462 companies for Interest Coverage. This places Medprin Regenerative Medical Technologies Co in the top 23% of its industry — outperforming the majority of peers. The industry median Interest Coverage is 16.76. Medprin Regenerative Medical Technologies Co's value of 492.04 is 2836.7% above this benchmark. Historically, Medprin Regenerative Medical Technologies Co's own Interest Coverage has ranged from 18.58 to 6,346.80 over the past decade. While the company's 10-year median is 96.22 vs. the industry median of 16.76, Medprin Regenerative Medical Technologies Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 16.76, based on 462 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medprin Regenerative Medical Technologies Co's current Interest Coverage of 492.04 is 2836.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Medprin Regenerative Medical Technologies Co and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 16.76 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medprin Regenerative Medical Technologies Co's current Interest Coverage is 492.04, which is 411% above median its own 10-year median of 96.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medprin Regenerative Medical Technologies Co stock overvalued right now?
Based on GuruFocus' analysis, Medprin Regenerative Medical Technologies Co (SZSE:301033) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥73.45, compared to a current price of ¥53.89 — trading 26.6% below its estimated fair value. The current Interest Coverage is 492.04, which is 411% above median its 10-year median of 96.22 and 2836.7% above the Medical Devices & Instruments industry median of 16.76. Medprin Regenerative Medical Technologies Co's overall GF Score™ is 78/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Medprin Regenerative Medical Technologies Co (SZSE:301033), the current Interest Coverage is 492.04 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medprin Regenerative Medical Technologies Co (SZSE:301033) Overvalued in 2026?
Based on GuruFocus' analysis, Medprin Regenerative Medical Technologies Co stock appears to be undervalued.
The current stock price of ¥53.89 is trading 26.6% below its estimated GF Value™ of ¥73.45.
GuruFocus considers Medprin Regenerative Medical Technologies Co to be Modestly Undervalued.
Key valuation signals for SZSE:301033:
Interest Coverage: 492.04 (411% above median its 10-year median of 96.22)
GF Value™: ¥73.45 vs. price of ¥53.89 (26.6% below fair value)
Industry Position: 2836.7% above the Medical Devices & Instruments median (#107 of 462)
No single metric tells the full story. See the SZSE:301033 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:301033 has been successfully added to your 
